Sanofi to acquire Dosch's veterinary health unit

Merial, the animal health division of Sanofi, has announced plans of acquiring the animal health arm of Mumbai-based Dosch Pharmaceuticals

images-acquisition

Merial to to acquire the animal health division of Mumbai-based Dosch Pharmaceuticals

The French drug company Sanofi recently announced its decision to enter into a binding agreement to acquire the animal health division of Dosch Pharmaceuticals, creating a market entry for its animal health division, Merial, in the strategically important and growing animal health sector. The agreement is subjected to regulatory approval and is expected to be finalized in the first half of 2013.

Dosch Pharmaceuticals, headquartered in Mumbai was incorporated in 1992 and is a diversified pharmaceutical company, primarily operating through two divisions, animal health and exports. The animal health division being acquired by Merial has more than 86 products under 50 brands for ruminants, poultry and companion animals. Products include an extensive range of animal health therapeutics and nutritional feed supplements. Within the animal health division, Dosch has a 279 member sales force, covering 18 Indian states. Merial employs approximately 5,600 people and operates in more than 150 countries worldwide.

"The acquisition of Dosch's Animal Health Division will be a significant milestone for Merial and give us a strategic platform for our development in the Indian market," said Mr Jose Barella, chief executive officer, Merial. "We are convinced that the combination of Dosch's animal health brands and distribution strength, along with the robust new product pipelines from both Merial and Dosch, will strongly position Merial to become rapidly a major animal health player in India," Mr Barella added.

"The strong nationwide sales, marketing and distribution network of Dosch, along with established products and people will be an ideal platform for Merial to enter the fast developing animal health market of India. Merial's entry will further strengthen the existing offering of Dosch's animal health business and provide a larger canvas for the market and the Dosch team," said Mr Sanjay Doshi, chairman and managing director, Dosch Pharmaceuticals.

Dr Sharat Tugnait, CEO, Dosch Pharma and his management team will manage the future combined operations of Dosch and Merial in India under the supervision of Mr Mayank Parekh, Merial country manager for India.

According to Merial, the animal health market in India is estimated to be more than €350 million in 2012, and is experiencing annual double-digit growth. India is home to the world's largest herd of cattle and buffalo, has the second largest herd of sheep and goats, and world's fifth largest population of poultry. India is also the world's largest milk producer.

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

Survey Box

GST

GST: Boon or Bane for Healthcare?

Send this article by email

X